Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Dianhydrogalactitol × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 5 Gynecologic 1

Conditions

Ovarian Neoplasms 1

Interventions

Paclitaxel 492 Carboplatin 453 Cisplatin 292 Bevacizumab 215 pembrolizumab 191 Gemcitabine 124 olaparib 111 Cyclophosphamide 111 liposomal doxorubicin 104 Topotecan 103 Radiotherapy 102 Taxes 88 Brachytherapy 81 Docetaxel 80 Drug Therapy 77 niraparib 74 Doxorubicin 74 Surveys and Questionnaires 70 Magnetic Resonance Spectroscopy 64 Nivolumab 61 Specimen Handling 60 Blood Specimen Collection 59 Biopsy 56 Hyperthermic Intraperitoneal Chemotherapy 53 fludarabine 51 Filgrastim 43 durvalumab 41 Letrozole 40 Surgical Procedures, Operative 39 Oxaliplatin 38

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03281681 2019-10-18

REPROVe

Kintara Therapeutics, Inc.

Phase 1/2 Withdrawn

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡